Page 1 | Search Results | Hematology, ASH Education Program

1-8 of 8

Sort by

Sort Order Select

Journal Articles

Idiopathic aplastic anemia vs hypocellular myelodysplastic syndrome

Jibran Durrani, Jaroslaw P. Maciejewski

Hematology Am Soc Hematol Educ Program (2019) 2019 (1): 97–104.

https://doi.org/10.1182/hematology.2019000019

Published: 2019

Journal Articles

Do somatic mutations in de novo MDS predict for response to treatment?

Mark A. Schroeder, Amy E. DeZern

Hematology Am Soc Hematol Educ Program (2015) 2015 (1): 317–328.

https://doi.org/10.1182/asheducation-2015.1.317

Published: 2015

Journal Articles

Malignant or benign leukocytosis

Tracy I. George

Hematology Am Soc Hematol Educ Program (2012) 2012 (1): 475–484.

https://doi.org/10.1182/asheducation.V2012.1.475.3798515

Published: 2012

Journal Articles

Novel therapeutic strategies: hypomethylating agents and beyond

Valeria Santini

Hematology Am Soc Hematol Educ Program (2012) 2012 (1): 65–73.

https://doi.org/10.1182/asheducation.V2012.1.65.3806843

Published: 2012

Journal Articles

In elderly patients with AML, which patients should be considered fit or unfit for standard induction therapy?

Ronan Swords, Valeria Santini

Hematology Am Soc Hematol Educ Program (2012) 2012 (1): 74–75.

https://doi.org/10.1182/asheducation.V2012.1.74.3806844

Published: 2012

Journal Articles

Evidence-Based Mini-Review: Should Patients Over the Age of 60 with INT-2 or High-Risk Myelodysplastic Syndrome Undergo Allogeneic Stem Cell Transplantation Prior to Progression to Acute Myelogenous Leukemia?

Mark A. Schroeder, William Blum

Hematology Am Soc Hematol Educ Program (2010) 2010 (1): 322–324.

https://doi.org/10.1182/asheducation-2010.1.322

Published: 2010

Journal Articles

MDS: A Stem Cell Disorder—But What Exactly Is Wrong with the Primitive Hematopoietic Cells in This Disease?

Stephen D. Nimer

Hematology Am Soc Hematol Educ Program (2008) 2008 (1): 43–51.

https://doi.org/10.1182/asheducation-2008.1.43

Published: 2008

Journal Articles

Hematopathological Concepts and Controversies in the Diagnosis and Classification of Myelodysplastic Syndromes

James W. Vardiman

Hematology Am Soc Hematol Educ Program (2006) 2006 (1): 199–204.

https://doi.org/10.1182/asheducation-2006.1.199

Published: 2006

NARROW

Idiopathic aplastic anemia vs hypocellular myelodysplastic syndrome

Do somatic mutations in de novo MDS predict for response to treatment?

Malignant or benign leukocytosis

Novel therapeutic strategies: hypomethylating agents and beyond

In elderly patients with AML, which patients should be considered fit or unfit for standard induction therapy?

Evidence-Based Mini-Review: Should Patients Over the Age of 60 with INT-2 or High-Risk Myelodysplastic Syndrome Undergo Allogeneic Stem Cell Transplantation Prior to Progression to Acute Myelogenous Leukemia?

MDS: A Stem Cell Disorder—But What Exactly Is Wrong with the Primitive Hematopoietic Cells in This Disease?

Hematopathological Concepts and Controversies in the Diagnosis and Classification of Myelodysplastic Syndromes

ASH Publications

American Society of Hematology

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only